On April 7, 2006, the Company signed a Definitive Agreement to acquire China BioPharma Limited (CBP), a Cayman island Company, which has majority ownership rights to Tianyuan Bio-pharmaceuticals Co. Ltd., based out of Zhejiang Province, China, pending on the Chinese government's final approval. According to the agreement, Techedge Inc. will acquire 100% of the outstanding capital stock of CBP in exchange for 3,000,000 unregistered shares of Techedge's common stock to be issued. In exchange for 100% of the outstanding capital of CBP, the Company issued a total of 3,000,000 shares of restricted common stock.
Market Data 
Markets 
AI
